TY - JOUR
AU - J. D. Scheidell
AU - M. Pitre
AU - B. Andraka-Christou
A1 - 
AB - Background: Research describes inequities in substance use treatment, but few studies focus specifically on racial and ethnic disparities in a range of aspects of substance use treatment among women with opioid use disorder (OUD).Objective: To examine whether substance use treatment (i.e. receipt, sources, barriers) differs by race and ethnicity among women with opioid use disorder (OUD) and to identify factors associated with treatment gap (i.e. needing treatment but not receiving it).Methods: We performed cross-sectional analyses using National Survey on Drug Use and Health 2015-2019 data, restricted to non-Hispanic Black, non-Hispanic White, and Hispanic women with past-year OUD (unweighted n = 1089). We estimated the prevalence of aspects of treatment among racial and ethnic groups, and used modified Poisson regression to estimate correlates of reported treatment gap.Results: Approximately 68% of White versus 87% of Black and 81% of Hispanic women with OUD had a treatment gap (p-value 0.0034). Commonly reported barriers to treatment included prioritization, affordability, and stigma. Older age was associated with lower prevalence of treatment gap among all women [prevalence ratio (PR) = 0.83, and 95% confidence interval (CI): 0.76, 0.92], while criminal legal involvement and healthcare coverage was associated with a lower prevalence of treatment gap among Hispanic and White women only (past year arrest: Hispanic women PR = 0.38, 95% CI: 0.17, 0.86; White women PR = 0.62, 95% CI: 0.47, 0.82).Conclusions: Receipt of treatment is low among women with OUD, especially Black and Hispanic women. Intersectional intervention approaches are needed to increase access and reduce inequities.
AD - Department of Health Sciences, College of Health Professions and Sciences, University of Central Florida, Orlando, United States.; Department of Social Work, College of Health Professions and Sciences, University of Central Florida, Orlando, United States.; School of Global Health Management and Informatics, College of Community Innovation and Education, University of Central Florida, Orlando, United States.
AN - 38295349
BT - Am J Drug Alcohol Abuse
C5 - Opioids & Substance Use; Healthcare Disparities
CP - 1
DA - Jan 2
DO - 10.1080/00952990.2023.2291748
DP - NLM
ET - 20240131
IS - 1
JF - Am J Drug Alcohol Abuse
LA - eng
N2 - Background: Research describes inequities in substance use treatment, but few studies focus specifically on racial and ethnic disparities in a range of aspects of substance use treatment among women with opioid use disorder (OUD).Objective: To examine whether substance use treatment (i.e. receipt, sources, barriers) differs by race and ethnicity among women with opioid use disorder (OUD) and to identify factors associated with treatment gap (i.e. needing treatment but not receiving it).Methods: We performed cross-sectional analyses using National Survey on Drug Use and Health 2015-2019 data, restricted to non-Hispanic Black, non-Hispanic White, and Hispanic women with past-year OUD (unweighted n = 1089). We estimated the prevalence of aspects of treatment among racial and ethnic groups, and used modified Poisson regression to estimate correlates of reported treatment gap.Results: Approximately 68% of White versus 87% of Black and 81% of Hispanic women with OUD had a treatment gap (p-value 0.0034). Commonly reported barriers to treatment included prioritization, affordability, and stigma. Older age was associated with lower prevalence of treatment gap among all women [prevalence ratio (PR) = 0.83, and 95% confidence interval (CI): 0.76, 0.92], while criminal legal involvement and healthcare coverage was associated with a lower prevalence of treatment gap among Hispanic and White women only (past year arrest: Hispanic women PR = 0.38, 95% CI: 0.17, 0.86; White women PR = 0.62, 95% CI: 0.47, 0.82).Conclusions: Receipt of treatment is low among women with OUD, especially Black and Hispanic women. Intersectional intervention approaches are needed to increase access and reduce inequities.
PY - 2024
SN - 0095-2990
SP - 106
EP - 116+
ST - Racial and ethnic inequities in substance use treatment among women with opioid use disorder
T1 - Racial and ethnic inequities in substance use treatment among women with opioid use disorder
T2 - Am J Drug Alcohol Abuse
TI - Racial and ethnic inequities in substance use treatment among women with opioid use disorder
U1 - Opioids & Substance Use; Healthcare Disparities
U3 - 10.1080/00952990.2023.2291748
VL - 50
VO - 0095-2990
Y1 - 2024
ER -